We are pleased to announce that we have appointed Simon Wright as Argenta’s Head of Global Commercial Operations, effective immediately.
Simon is responsible for supporting new business and will be the commercial partner for allocated key customers. In this capacity, he will work closely together with Phil Huse, Chief Commercial Officer at Argenta, to ensure a seamless transition in anticipation of Phil’s retirement later this year. Simon is a member of Argenta’s Senior Leadership Team and reports to Mark Bridgewater, Chief Business & Growth officer.
“Simon’s experience of both operational and commercial frameworks within the Pharmaceutical Contract Development and Manufacturing industry, ideally positions him to support our customer base and enable their needs to drive successful outcomes,” said Mark Bridgewater. “This appointment allows us to ensure we offer our customers complete access to the full range of Molecule to Market services and supports Argenta’s ongoing objectives to have customer excellence top of mind in everything we do.”
Prior to joining Argenta, Simon was with Catalent Pharma Solutions as their Regional Head Commercial Operations – Pharma Product Delivery Division. Simon has a proven track record in building strong relationships with internal teams and customers, which have contributed to delivering outstanding results and service excellence.
Simon Wright said: “I am thrilled to be joining Argenta at this exciting time for the company and at this stage in my career. I look forward to supporting the execution of the strategic plan and driving overall business growth.”
Founded in New Zealand, Argenta’s talented and committed employees are dedicated to delivering excellence in animal health to customers around the world. With research and/or GMP manufacturing operations in Germany, New Zealand, Spain, the United Kingdom, and the United States, Argenta holds a unique position as the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialising in animal health and nutrition.
We operate from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research and development, clinical research, regulatory, scale-up and manufacturing needs along the veterinary product development journey.
The day-to-day ethos that drives us forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of our business and organisation is collaboration – among our global employee base and with our customers.
Please don’t hesitate to get in touch if you are interested in our services.